In the race to combine niacin with a generic version of Merck's off-patent statin simvastatin, Abbott appears to have pole position.
SIGN IN WITH ONE OF YOUR SOCIAL ACCOUNTS
Sign in with your MMM account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH ONE OF YOUR SOCIAL ACCOUNTS
REGISTER FOR FREE WITH A MMM ACCOUNT
Enter your MMM registration email address to receive a new password.